Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 3/20 | 0.61 |
| ▸ | FNTB | P49356 | 3/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CRHBP | P24387 | 1/20 | 0.42 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23699693 | 1.00 | FNTA (0.61) | FNTAFNTBALDH1A1NPSR1CA2 | |
| SCHEMBL21794720 | 0.89 | FNTA (0.49) | FNTAFNTBALDH1A1CRHBPCRHR2 | |
| SCHEMBL23712605 | 0.89 | FNTA (0.49) | FNTAFNTBALDH1A1CRHBPCRHR2 | |
| SCHEMBL21776957 | 0.87 | FNTA (0.48) | FNTAFNTBALDH1A1CRHBPCRHR2 | |
| SCHEMBL21776958 | 0.87 | FNTA (0.48) | FNTAFNTBALDH1A1CRHBPCRHR2 | |
| Hydrochloric Acid SCHEMBL23699686 | 0.84 | PPID (0.47) | FNTAFNTBALDH1A1NPSR1CA2 | |
| Hydrochloric Acid SCHEMBL23699687 | 0.84 | PPID (0.47) | FNTAFNTBALDH1A1NPSR1CA2 | |
| SCHEMBL8602967 | 0.77 | FNTA (0.62) | FNTAFNTBALDH1A1NPSR1CA2 | |
| SCHEMBL8602966 | 0.77 | FNTA (0.62) | FNTAFNTBALDH1A1NPSR1CA2 | |
| SCHEMBL8937074 | 0.76 | FNTA (1.00) | FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11802108-B2 | Compounds for the modulation of cyclophilins function | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2023-10-31 | — | — | US | disclosed |
| US-20210238130-A1 | COMPOUNDS FOR THE MODULATION OF CYCLOPHILINS FUNCTION | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2021-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11802108-B2 | Compounds for the modulation of cyclophilins function | CBR1, CBR3, PPIC | FNTA 2895/4885FNTB 1347/4885ALDH1A1 2150/4885 |
| US-20210238130-A1 | COMPOUNDS FOR THE MODULATION OF CYCLOPHILINS FUNCTION | CBR1, CBR3, PPIC | FNTA 2895/4885FNTB 1347/4885ALDH1A1 2150/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.